CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net earnings (loss)	$ 15,106	$ (1,317)
Adjustments to reconcile net earnings (loss) to net cash (used in) provided by operating activities:
Provision for credit losses	11,314	15,910
Depreciation	9,948	23,849
Deferred income taxes	2,717	1,253
Non-cash lease expense (including impairment of right-of-use assets)	1,786	4,752
Stock-based compensation expense	(2,287)	9,397
Other adjustments, net	(451)	384
Changes in assets and liabilities:
Accounts receivable	(14,773)	(25,761)
Other assets	2,469	13,320
Accounts payable and other liabilities	(20,390)	(17,417)
Operating lease liabilities	(3,270)	(4,487)
Income taxes payable and receivable	1,417	2,148
Deferred revenue	(6,699)	265
Net cash (used in) provided by operating activities	(3,113)	22,296
Cash flows from investing activities:
Capital expenditures	(12,574)	(12,798)
Proceeds from sales of fixed assets	75	6
Net cash used in investing activities	(12,499)	(12,792)
Cash flows from financing activities:
Purchases of treasury stock	(9,801)	(6,860)
Withholding taxes paid on behalf of employees on net settled stock-based awards	(4,542)	(3,214)
Net cash used in financing activities	(14,343)	(10,074)
Total cash used	(29,955)	(570)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(26)	(141)
Net decrease in cash and cash equivalents and restricted cash	(29,981)	(711)
Cash and cash equivalents and restricted cash at beginning of period	416,545	364,301
Cash and cash equivalents and restricted cash at end of period	$ 386,564	$ 363,590